Accordingly to the trend of CD68 pattern, the number of CD68/Gal-3+ macrophages was also significantly reduced only in patients diagnosed with steatosis and NASH (Figure 2C,D). This evidence concerns the gene LGALS3 and metabolic dysfunction-associated steatohepatitis.